Abstract

Long non-coding RNAs (lncRNAs) have been involved in occurrence and progression of multiple cancers. In the present study, we investigated the role of lncRNA Gm15290 in the proliferation and invasion of non-small cell lung cancer (NSCLC) cells. First, we found that lncRNA Gm15290 was markedly up-regulated in tumor tissues from NSCLC patients and NSCLC cell lines, compared with adjacent normal tissues and normal lung cell line HBE respectively. Then, different concentrations of pcDNA-Gm15290 expression vector and Gm15290 siRNA were respectively transfected into A549 NSCLC cells. Our results showed that overexpression of Gm15290 significantly increased the proliferation and invasion of A549 cells and suppressed cell apoptosis. Knockdown of Gm15290 suppressed A549 cell proliferation and invasion and promoted cell apoptosis. Subsequently, we explored the underlying mechanism through which Gm15290 promoted cell proliferation and invasion. The output of RNA hybrid bioinformatic tool revealed that Gm15290 potentially interacted with tumor suppressor miR-615-5p which displayed an opposite expression pattern in the cell lines and a strong negative correlation with the levels of Gm15290 in NSCLC patients (r2 = 0.9677, P<0.0001). The results of RNA pull-down assays confirmed that Gm15290 directly bound with miR-615-5p. Gm15290 negatively regulated the expression of miR-615-5p and increased the protein levels of miR-615-5p target genes, including IGF2, AKT2, and SHMT2. Moreover, miR-615-5p mimic could antagonize the promoting effect of Gm15290 on cell proliferation and invasion.

Highlights

  • Lung cancer has become the leading cause of cancer death in China

  • Results long non-coding RNA (lncRNA) Gm15290 was significantly up-regulated in human Non-small cell lung cancers (NSCLC) tissues and cell line

  • Expression of lncRNA Gm15290 in cancerous tissues and matched adjacent normal tissues from 30 NSCLC patients was detected with real-time qPCR

Read more

Summary

Introduction

Lung cancer has become the leading cause of cancer death in China. Non-small cell lung cancers (NSCLC), including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma, account for more than 80% of lung cancer cases [1]. In contrast with small cell lung cancer cells, the growth and division of NSCLC cells are much quicker, and their invasion to adjacent tissues and distant metastasis are much earlier [2,3]. More than half of the non-small cell lung tumors are diagnosed at advanced stages, so that the 5-year survival rate of NSCLC patients is lower than 15% [4,5,6]. The pathogenesis of NSCLC is not yet fully understood. It is urgent to unearth reliable diagnostic and therapeutic targets for NSCLC

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.